<DOC>
	<DOCNO>NCT00862745</DOCNO>
	<brief_summary>Six hundred thirty-six woman diagnose urge urinary incontinence ( UUI ) three-item self-administered questionnaire ( 3IQ ) randomize 12 week fesoterodine match placebo . The study take place 14 clinical site US . All participant complete 12-week randomize trial offer open-label fesoterodine additional 9 month . The hypothesis randomize control trial among woman diagnose urge incontinence use 3IQ , fesoterodine effective placebo reduce mean number urge incontinence episode per day .</brief_summary>
	<brief_title>Bringing Simple Urge Incontinence Diagnosis &amp; Treatment Providers ( BRIDGES )</brief_title>
	<detailed_description />
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Urinary Incontinence , Urge</mesh_term>
	<mesh_term>Fesoterodine</mesh_term>
	<criteria>Ambulatory female ≥ 18 year old Urge Urinary Incontinence ( subjectreported ) ≥ 3 month prior Screening ( Visit 1 ) On 3IQ : Response b Question 3 : During last 3 month , leak urine often : b . When urge feeling need empty bladder , could get toilet fast enough ? On 3day bladder diary , documentation average 1 UUI episode per 24 hour ( 3 UUI episode 3 day ) Capability understand sign informed consent form full discussion research nature treatment risk benefit Ability perform procedure test require protocol Willingness remain stable medication regime duration randomize control trial . Participants ask add new medication randomize controlled trial , diuretic medication may affect void pattern . Any condition would contraindicate usage fesoterodine include : hypersensitivity active drug ( fesoterodine fumarate ) ingredients excipients , history urinary retention , gastric retention , uncontrolled narrow angle glaucoma , myasthenia gravis , severe hepatic impairment ( Child Pugh C ) , severe ulcerative colitis , toxic megacolon , fistula hole bladder rectum , birth defect lead urine leakage , urine leakage start childhood . Clinically significant hepatic renal disease . Neurologic condition stroke , multiple sclerosis , spinal cord injury , Parkinson 's disease . Symptomatic pelvic organ prolapse define participant report feel see bulge outside vagina within past 3 month . History low urinary tract/pelvic surgery ( e.g . surgery incontinence past 5 year , surgery past 6 month prolapse hysterectomy ) , intravesical therapy ( botox ) , and/or bulk injection within past 6 month . A known history interstitial cystitis significant pain component associate OAB symptom , uninvestigated hematuria , urogenital cancer , interstitial external radiation pelvis external genitalia . Urinary tract infection ( UTI ) show result urinalysis screening recurrent urinary tract infection ( RUTIs ) define treatment UTI &gt; 3 time last year . Use electrostimulation , bladder training , pelvic floor exercise ( certify incontinence practitioner ) within 4 week Screening . Received study medication previous fesoterodine clinical trial . Prior failure either efficacy tolerability ≥ 2 OAB medication last year . ( failure : inadequate symptom control two medication minimum one month ) Has treat within 2 week prior Screening and/or currently treat : Any drug treatment overactive bladder , include antimuscarinic OAB medication . Any drug significant anticholinergic antispasmodic effect ( see exception tricyclic antidepressant ) Has start treatment tricyclic antidepressant estrogens within 4 week prior Screening and/or stable dose . Intermittent unstable use diuretic . Treatment diuretic initiate within 2 week prior baseline permit . Treatment potent CYP3A4 inhibitor , clarithromycin , ketoconazole , itraconazole within 2 week prior Screening . Administration medication capable induce hepatic enzyme metabolism transport ( e.g. , barbiturate , rifampicin , carbamazepine , phenytoin , primidone , St. John 's Wort ) past 30 day . Previously receive investigational drug within 30 day prior trial entry . Alcohol and/or drug abuse opinion investigator . Participants pregnant , nursing , positive urine pregnancy test intend become pregnant within 3 month completion trial . Participants pregnant ( &gt; 20 week gestation ) previous 6 month . Participants childbearing potential heterosexually active unwilling unable use adequate form contraception prevent pregnancy study . Reliable contraceptive method may include intrauterine device ( IUD ) , contraceptive pill combination type , hormonal implant , injectable contraceptive latex condom spermicide . Participants medical ( include know history major hematological , renal , cardiovascular , hepatic abnormality ) psychological condition social circumstance would impair ability participate reliably trial , may increase risk others participate . Participants , opinion investigator , likely complete trial whatever reason .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
</DOC>